| In EUR m | Q3 2022 | Q3 2021 | 9M 2022 | 9M 2021 |
| Revenue | 436.3 | 414.3 | 1,246.3 | 1,100.2 |
| EBITDA (adjusted) | 133.6 | 138.7 | 353.9 | 318.9 |
| Exceptional items | -2.7 | -2.5 | 5.4 | -5.6 |
| EBITDA | 130.9 | 136.1 | 359.3 | 313.3 |
| Amortization, depreciation and impairment losses | -73.3 | -75.6 | -219.6 | -231.1 |
| thereof attributable to purchase price allocations and impairment losses | -6.8 | -14.6 | -20.3 | -37.5 |
| EBIT | 57.6 | 60.5 | 139.7 | 82.2 |
| Net finance income/costs | -5.4 | -7.4 | -17.7 | -21.5 |
| EBT | 52.2 | 53.1 | 122.0 | 60.7 |
| Taxes | -13.0 | -12.9 | -29.1 | -14.8 |
| Consolidated profit or loss for the period | 39.1 | 40.2 | 92.9 | 45.9 |
| Adjusted consolidated profit or loss for the period | 46.3 | 56.2 | 104.2 | 83.4 |
| Free cash flow (before M&A transactions) | 32.2 | 76.7 | 115.9 | 159.4 |
| Net debt (Sep. 30 / Dec 31.) | 739.7 | 612.3 |
